PT952982E - Novos inibidores da hepatite b - Google Patents

Novos inibidores da hepatite b

Info

Publication number
PT952982E
PT952982E PT97946476T PT97946476T PT952982E PT 952982 E PT952982 E PT 952982E PT 97946476 T PT97946476 T PT 97946476T PT 97946476 T PT97946476 T PT 97946476T PT 952982 E PT952982 E PT 952982E
Authority
PT
Portugal
Prior art keywords
inhibitors
new hepatitis
hepatitis
new
peptides
Prior art date
Application number
PT97946476T
Other languages
English (en)
Inventor
Kenneth Murray
Michael Richard Dyson
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of PT952982E publication Critical patent/PT952982E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97946476T 1996-10-31 1997-10-31 Novos inibidores da hepatite b PT952982E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3053496P 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
PT952982E true PT952982E (pt) 2004-03-31

Family

ID=21854673

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97946476T PT952982E (pt) 1996-10-31 1997-10-31 Novos inibidores da hepatite b

Country Status (11)

Country Link
US (1) US6544520B1 (pt)
EP (1) EP0952982B1 (pt)
JP (2) JP4091663B2 (pt)
AT (1) ATE255594T1 (pt)
AU (1) AU5163598A (pt)
CA (1) CA2270401A1 (pt)
DE (1) DE69726602T2 (pt)
DK (1) DK0952982T3 (pt)
ES (1) ES2207753T3 (pt)
PT (1) PT952982E (pt)
WO (1) WO1998018818A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770225B2 (en) 1998-12-04 2004-02-19 Biogen Idec Ma Inc. HBV core antigen particles with multiple immunogenic components attached via peptide ligands
KR100746991B1 (ko) 2004-08-06 2007-08-08 한국과학기술연구원 Hbv 코아 단백질과 표면 단백질 간 상호작용의 측정을이용한 hbv의 증식 억제물질의 검색방법
KR100949310B1 (ko) * 2007-11-21 2010-03-23 한국과학기술연구원 세포 영상 기법을 이용한 hbv 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 hbv 증식억제물질의 검색방법
CN101503461B (zh) * 2009-02-12 2011-09-07 北京大学人民医院 一种具有诱导肝癌细胞凋亡功能的多肽
CN120897691A (zh) 2023-01-19 2025-11-04 尚科宁家运营有限公司 具有被供电的附件的毛发护理用具
US20240245190A1 (en) 2023-01-19 2024-07-25 Sharkninja Operating Llc Identification of hair care appliance attachments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204096A (en) 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5296572A (en) 1986-04-30 1994-03-22 James Sparrow Large pore polyamide resin and method of preparation thereof
JP2661044B2 (ja) 1986-06-17 1997-10-08 カイロン コーポレイション 肝炎δの診断薬およびワクチン
JPH02273700A (ja) 1989-04-14 1990-11-08 Olympus Optical Co Ltd ペプチド
US5547669A (en) 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
KR940000755B1 (ko) 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5556744A (en) 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5531990A (en) 1993-12-15 1996-07-02 Health Research, Inc. Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen
US5856459A (en) 1995-06-06 1999-01-05 Hybridon, Inc. Oligonucleotides specific for hepatitis B virus

Also Published As

Publication number Publication date
EP0952982B1 (en) 2003-12-03
ES2207753T3 (es) 2004-06-01
ATE255594T1 (de) 2003-12-15
JP2008120814A (ja) 2008-05-29
DE69726602D1 (en) 2004-01-15
JP2001503750A (ja) 2001-03-21
JP4091663B2 (ja) 2008-05-28
US6544520B1 (en) 2003-04-08
WO1998018818A2 (en) 1998-05-07
AU5163598A (en) 1998-05-22
DK0952982T3 (da) 2004-03-29
DE69726602T2 (de) 2004-09-30
EP0952982A2 (en) 1999-11-03
WO1998018818A3 (en) 1998-07-09
CA2270401A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
EA199801031A1 (ru) Ингибиторы протеинфарнезилтрансферазы
CY1106156T1 (el) Νεα χρηση βουδεσονιδης και φορμοτepολης
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
EP1019365A4 (en) NOVEL NEGATIVELY LOADED MOLECULE DELIVERY COMPOSITIONS
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DE69939864D1 (de) Ppar-gamma modulatoren
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
NO982310L (no) Protegriner
EA199900621A1 (ru) Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1
BR9707819A (pt) Imunogenos peptidicos
DE69905170T2 (de) Thiazolopyrimidinderivate
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
DE69938935D1 (de) Zyklische conotoxin-peptide
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
DE69616074D1 (de) Ara-c derivate
PT952982E (pt) Novos inibidores da hepatite b
EA200001164A1 (ru) КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
BG100248A (bg) Инхибитори на скваленсинтетаза
NO981019L (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
MX9602718A (es) Hidrofluoroalcanos como solventes de limpieza y desengrasado.
ATE385805T1 (de) Neue peptide